Phase Ib of L-NMMA and Pembrolizumab
The Methodist Hospital Research Institute
The Methodist Hospital Research Institute
IO Biotech
University Hospital, Caen
H. Lee Moffitt Cancer Center and Research Institute
Fudan University
Merck Sharp & Dohme LLC
Dana-Farber Cancer Institute
Rowan University
UNC Lineberger Comprehensive Cancer Center
Medical College of Wisconsin
University of Colorado, Denver
Seagen Inc.
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
University of Kentucky
Hospices Civils de Lyon
National Cancer Institute (NCI)
University of Michigan Rogel Cancer Center
Eastern Cooperative Oncology Group
Dana-Farber Cancer Institute
R-Pharm
University of Texas Southwestern Medical Center
University of Leipzig
University of California, San Diego
Mayo Clinic
National Cancer Institute (NCI)
Merck Sharp & Dohme LLC
Amgen
Icahn School of Medicine at Mount Sinai
Heidelberg University
University of California, San Diego
University of Michigan Rogel Cancer Center
CHU de Reims
Xinqiao Hospital of Chongqing
Xinqiao Hospital of Chongqing
Washington University School of Medicine
Hôpital de la Croix-Rousse
Radiation Therapy Oncology Group
University of Pittsburgh
Maastricht University Medical Center
Centre Henri Becquerel
Centre Henri Becquerel
Pharmassist Ltd
Jacobio Pharmaceuticals Co., Ltd.
Kura Oncology, Inc.
Seagen Inc.
University of Pittsburgh
Immutep S.A.S.
H. Lee Moffitt Cancer Center and Research Institute
Merck Sharp & Dohme LLC